Rallybio Corp (RLYB) stock
RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.26−0.03 (-0.20%)
Close on Nov 18, 2026Market cap $82.16MP/E 3.3Yield –
Rallybio market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Rallybio's market cap was $83.85M on Nov 11, 2026, against $27.30M a year earlier. Over the last 5 years it ranged from $12.86M to $464.94M, with a median of $83.85M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $83.85M | +191.4% |
| 2025 | Dec 31, 2025 | $28.77M | -27.8% |
| 2024 | Dec 31, 2024 | $39.83M | -55.9% |
| 2023 | Dec 29, 2023 | $90.34M | -57.2% |
| 2022 | Dec 30, 2022 | $210.84M | -31.2% |
| 2021 | Dec 31, 2021 | $306.52M | – |
See a number that looks wrong?